GTx, Oncternal Therapeutics sign merger deal to create new clinical-stage oncology firm

Image: Oncternal Therapeutics will focus on development of potential first-in-class therapeutic candidates for cancers. Photo: courtesy of sscreations / FreeDigitalPhotos.net.